LTA4H expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.986360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.202400E-02
Normal-vs-Stage2
2.473200E-01
Normal-vs-Stage3
5.652300E-02
Normal-vs-Stage4
4.041000E-01
Stage1-vs-Stage2
6.111800E-01
Stage1-vs-Stage3
1.731750E-01
Stage1-vs-Stage4
1.915990E-01
Stage2-vs-Stage3
9.566400E-02
Stage2-vs-Stage4
6.107800E-01
Stage3-vs-Stage4
8.789700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.174600E-01
Normal-vs-AfricanAmerican
3.568200E-02
Normal-vs-Asian
4.401600E-02
Caucasian-vs-AfricanAmerican
3.029600E-01
Caucasian-vs-Asian
1.213850E-01
AfricanAmerican-vs-Asian
8.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.574010E-01
Normal-vs-Female
2.600800E-01
Male-vs-Female
6.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.071900E-02
Normal-vs-Age(41-60Yrs)
3.008200E-01
Normal-vs-Age(61-80Yrs)
1.103790E-01
Normal-vs-Age(81-100Yrs)
8.653800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.464200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.849000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.330400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.502200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.341200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.554480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.188400E-01
Normal-vs-Daily Drinker
2.152400E-01
Normal-vs-Weekly Drinker
3.031700E-02
Normal-vs-Occasional Drinker
1.525440E-01
Normal-vs-Social Drinker
1.617600E-01
Non Drinker-vs-Daily Drinker
9.121000E-01
Non Drinker-vs-Weekly Drinker
4.199400E-01
Non Drinker-vs-Occasional Drinker
4.519200E-01
Non Drinker-vs-Social Drinker
7.784400E-01
Daily Drinker-vs-Weekly Drinker
3.533000E-01
Daily Drinker-vs-Occasional Drinker
5.674400E-01
Daily Drinker-vs-Social Drinker
8.571000E-01
Weekly Drinker-vs-Occasional Drinker
7.388300E-02
Weekly Drinker-vs-Social Drinker
2.242200E-01
Occasional Drinker-vs-Social Drinker
6.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.369750E-01
Normal-vs-Grade 2
1.300190E-02
Normal-vs-Grade 3
6.517900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.175600E-02
Grade 1-vs-Grade 3
6.919700E-02
Grade 1-vs-Grade 4
1.369750E-01
Grade 2-vs-Grade 3
4.203600E-01
Grade 2-vs-Grade 4
1.300190E-02
Grade 3-vs-Grade 4
6.517900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.095800E-01
Normal-vs-NonDiabetic
1.215810E-01
Diabetic-vs-NonDiabetic
3.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.106000E-01
Normal-vs-NoPancreatitis
1.525580E-01
Pancreatitis-vs-NoPancreatitis
9.290600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.281800E-02
Normal-vs-N1
2.805200E-01
N0-vs-N1
3.101000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.331500E-02
Normal-vs-TP53-NonMutant
4.559900E-03
TP53-Mutant-vs-TP53-NonMutant
2.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
